Design Therapeutics (DSGN) Shares Issued (2021 - 2026)

Design Therapeutics has disclosed Shares Issued across 6 years of filings, most recently posting $19.9 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $19.9 million, up 86452.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.1 million (up 51397.44% YoY), and the FY2025 annual result was $200000.0, up 455.56% from the prior year.
• Shares Issued came in at $19.9 million for Q1 2026 at Design Therapeutics, up from $140000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $19.9 million in Q1 2026 to a low of $1000.0 in Q3 2024.
• The 5-year median for Shares Issued is $23000.0 (2025), against an average of $1.6 million.
• Across the five-year window, Shares Issued tumbled 99.94% in 2022 and soared 86452.17% in 2026, its largest moves.
• Design Therapeutics' Shares Issued stood at $16000.0 in 2022, then jumped by 2293.75% to $383000.0 in 2023, then plunged by 97.65% to $9000.0 in 2024, then soared by 1455.56% to $140000.0 in 2025, then soared by 14119.29% to $19.9 million in 2026.
• The last three Shares Issued figures came in at $19.9 million (Q1 2026), $140000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.